NEW YORK, June 24-Boston's Partners health care system has struck a broad alliance with Zyomyx to use the company's protein chip system in clinical research.
Under a three-year agreement, Zyomyx and Partners together will establish a protein profiling research facility to identify and validate biomarkers associated with disease. No financial details were disclosed.
Zyomyx will provide a protein analysis system, which includes workstation, software and ready-to-use antibody chips.
Partners is a consortium of medical facilities that includes Harvard Medical School and its affiliated teaching hospitals, Massachusetts General Hospital and Boston's Brigham and Women's Hospital.
The agreement establishes Zyomyx's first major academic protein analysis research center.
For more information, see the company website.